Cann Global Limited (CGB:ASX) Annual Reports & Investor Relations Material

Overview

Cann Global Limited is an Australian company that operates in the medicinal cannabis and hemp food industries. The company has two main segments, Hemp and Medical Cannabis Products, and Mining Exploration and Evaluation. Their operations include growing and cultivating medical cannabis and hemp products, providing plant-based food and skincare, and exploring and developing bauxite mines. The company was previously known as Queensland Bauxite Limited before rebranding to Cann Global Limited in January 2019. It was incorporated in 2007 and is based in Sydney, Australia.

Frequently Asked Questions

What is Cann Global Limited's ticker?

Cann Global Limited's ticker is CGB

What exchange is Cann Global Limited traded on?

The company's shares trade on the ASX stock exchange

Where are Cann Global Limited's headquarters?

They are based in Subiaco, Australia

How many employees does Cann Global Limited have?

There are 11-50 employees working at Cann Global Limited

What is Cann Global Limited's website?

It is https://www.canngloballimited.com/

What type of sector is Cann Global Limited?

Cann Global Limited is in the Healthcare sector

What type of industry is Cann Global Limited?

Cann Global Limited is in the Drug Manufacturers - Other industry

Who are Cann Global Limited's peers and competitors?

The following five companies are Cann Global Limited's industry peers:

- Taro Pharmaceutical Industries

- Little Green Pharma

- Durect Corp.

- IDT

- Aurora Cannabis